Noevir Holdings Co Ltd
TSE:4928

Watchlist Manager
Noevir Holdings Co Ltd Logo
Noevir Holdings Co Ltd
TSE:4928
Watchlist
Price: 4 995 JPY 0.4% Market Closed
Market Cap: 170.6B JPY
Have any thoughts about
Noevir Holdings Co Ltd?
Write Note

Noevir Holdings Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Noevir Holdings Co Ltd
Cost of Revenue Peer Comparison

Comparables:
4911
4527
4452
4922
4967

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Noevir Holdings Co Ltd
TSE:4928
Cost of Revenue
-ÂĄ20.9B
CAGR 3-Years
-4%
CAGR 5-Years
0%
CAGR 10-Years
-3%
Shiseido Co Ltd
TSE:4911
Cost of Revenue
-ÂĄ246.2B
CAGR 3-Years
3%
CAGR 5-Years
-1%
CAGR 10-Years
-3%
Rohto Pharmaceutical Co Ltd
TSE:4527
Cost of Revenue
-ÂĄ117.4B
CAGR 3-Years
-16%
CAGR 5-Years
-9%
CAGR 10-Years
-7%
Kao Corp
TSE:4452
Cost of Revenue
-ÂĄ976.9B
CAGR 3-Years
-7%
CAGR 5-Years
-3%
CAGR 10-Years
-5%
Kose Corp
TSE:4922
Cost of Revenue
-ÂĄ94.6B
CAGR 3-Years
-7%
CAGR 5-Years
-1%
CAGR 10-Years
-7%
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Cost of Revenue
-ÂĄ78.3B
CAGR 3-Years
-6%
CAGR 5-Years
-4%
CAGR 10-Years
-4%

See Also

What is Noevir Holdings Co Ltd's Cost of Revenue?
Cost of Revenue
-20.9B JPY

Based on the financial report for Jun 30, 2024, Noevir Holdings Co Ltd's Cost of Revenue amounts to -20.9B JPY.

What is Noevir Holdings Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-3%

Over the last year, the Cost of Revenue growth was -7%. The average annual Cost of Revenue growth rates for Noevir Holdings Co Ltd have been -4% over the past three years , and -3% over the past ten years .

Back to Top